GLABF (Gemina Laboratories) ROE % Adjusted to Book Value : 0.00% (As of Jul. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Gemina Laboratories ROE % Adjusted to Book Value?

Gemina Laboratories's ROE % for the quarter that ended in Jul. 2024 was 0.00%. Gemina Laboratories's PB Ratio for the quarter that ended in Jul. 2024 was N/A. Gemina Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 was N/A.

Gemina Laboratories ROE % Adjusted to Book Value Historical Data

The historical data trend for Gemina Laboratories's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories ROE % Adjusted to Book Value Chart

Gemina Laboratories Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

ROE % Adjusted to Book Value

Gemina Laboratories Quarterly Data
	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-2.08	-	-	-	-

Competitive Comparison of Gemina Laboratories's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Gemina Laboratories's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gemina Laboratories's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's ROE % Adjusted to Book Value falls into.

Gemina Laboratories ROE % Adjusted to Book Value Calculation

Gemina Laboratories's ROE % Adjusted to Book Value for the fiscal year that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Gemina Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Gemina Laboratories ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (OTCPK:GLABF) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

8I7:Germany GLAB:Canada

Address

3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8

Website

https://www.geminalabs.com

Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.